Sensei Biotherapeutics to Present at BIO CEO & Investor Conference
GAITHERSBURG, Md.–(BUSINESS WIRE)–Sensei Biotherapeutics, Inc.., a clinical-stage biopharmaceutical company developing precision immuno-oncology therapies, announced today that John Celebi, President and Chief Executive Officer of Sensei Biotherapeutics, will present a company overview at the BIO CEO & …